Status:
COMPLETED
Study of the Efficacy of ESTRATEST® H.S. Tablets in Relieving Menopausal Symptoms in Estrogenized Postmenopausal Women
Lead Sponsor:
Solvay Pharmaceuticals
Conditions:
Menopause
Eligibility:
FEMALE
30-65 years
Phase:
PHASE2
Brief Summary
To determine whether treatment with ESTRATEST® H.S. Tablets is superior to treatment with esterified estrogens tablets
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Menopausal women between the ages of 30 and 65 years (inclusive) with symptoms of estrogen and/or androgen deficiency not currently controlled by estrogen therapy as determined by patient report and the Investigator's clinical judgement
Exclusion
Key Trial Info
Start Date :
June 1 2004
Trial Type :
INTERVENTIONAL
End Date :
June 1 2007
Estimated Enrollment :
350 Patients enrolled
Trial Details
Trial ID
NCT00141570
Start Date
June 1 2004
End Date
June 1 2007
Last Update
January 16 2015
Active Locations (77)
Enter a location and click search to find clinical trials sorted by distance.
1
Site 66
Huntsville, Alabama, United States
2
Site 57
Mobile, Alabama, United States
3
Site 46
Montgomery, Alabama, United States
4
Site 29
Phoenix, Arizona, United States